Tissue immunoassay for 19F-tagged 5-hydroxytryptophan.

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• Development of novel imaging agents is crucial for in vivo detection.
• L-6-heptafluorobutyryl-5-hydroxytryptophan is a new tool for magnetic resonance imaging.
• The compound needs to cross the blood-brain barrier and concentrate in serotonergic neurons.

Purpose of the Study:

• To synthesize and investigate a novel magnetic resonance imaging agent.
• To assess the bioavailability and uptake dynamics of the compound in vivo.
• To develop a new immunoassay technique for detecting the compound.

Main Methods:

• Synthesis of L-6-heptafluorobutyryl-5-hydroxytryptophan.
• Administration of the compound to domestic chicks (Gallus domestics) via ova.
• Development of a novel immunoassay technique utilizing acid-functionalized cuvettes for amine and amino acid binding.
• Tissue analysis (neural, liver, heart) and regional brain analysis (midbrain, frontal lobe, occipital lobe, cerebellum).

Main Results:

• Higher concentrations of the tagged compound were found in neural and liver tissues compared to heart tissue.
• The midbrain showed the highest concentration, followed by the frontal lobe, then occipital and cerebellum.
• Maximum brain concentration was achieved three days post-injection, indicating in vivo bioaccumulation.
• The compound's distribution mirrors the pathway of endogenous serotonin.
• The novel immunoassay demonstrated good repeatability.

Conclusions:

• L-6-heptafluorobutyryl-5-hydroxytryptophan is a promising candidate for in vivo imaging agent.
• The developed immunoassay is effective for detecting the novel compound in tissue samples.
• The compound's uptake dynamics and distribution support its potential use in targeting serotonergic pathways.